Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-05 Sale |
2025-03-07 4:17 pm |
Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO |
100,000 | $8.91 | $891,000 | 621,882 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-03 Option Award |
2025-03-05 7:53 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO |
342,465 | $0 | 1,356,260 (Direct) |
View |
| 2025-03-03 Tax Withholding |
2025-03-05 7:53 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO |
133,410 | $8.76 | 1,356,260 (Direct) |
View |
| 2025-03-04 Tax Withholding |
2025-03-05 7:53 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO |
22,497 | $8.84 | 1,356,260 (Direct) |
View |
| 2025-03-03 Exercise |
2025-03-05 7:53 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO |
327,770 | $0 | 1,356,260 (Direct) |
View |
| 2025-03-01 Exercise |
2025-03-04 6:59 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO |
36,197 | $0 | 550,019 (Direct) |
View |
| 2025-03-01 Tax Withholding |
2025-03-04 6:59 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO |
13,494 | $8.67 | 550,019 (Direct) |
View |
| 2024-03-12 Tax Withholding |
2024-03-14 4:17 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO |
30,790 | $5.31 | 527,316 (Direct) |
View |
| 2024-03-12 Exercise |
2024-03-14 4:17 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO |
87,720 | $0 | 527,316 (Direct) |
View |
| 2024-03-04 Option Award |
2024-03-05 4:56 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO |
527,778 | $0 | 1,296,960 (Direct) |
View |
| 2024-03-01 Exercise |
2024-03-05 4:56 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO |
138,826 | $0 | 1,296,960 (Direct) |
View |
| 2024-03-01 Tax Withholding |
2024-03-05 4:56 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO |
49,280 | $5.47 | 1,296,960 (Direct) |
View |
| 2023-03-12 Exercise |
2023-03-14 4:30 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO |
87,719 | $0 | 468,560 (Direct) |
View |
| 2023-03-03 Option Award |
2023-03-07 6:00 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO |
688,074 | $0 | 1,117,065 (Direct) |
View |
| 2023-03-03 Exercise |
2023-03-07 6:00 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO |
45,289 | $0 | 1,117,065 (Direct) |
View |
| 2023-03-01 Exercise |
2023-03-03 4:30 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO |
36,197 | $0 | 320,226 (Direct) |
View |
| 2022-03-12 Exercise |
2022-03-15 5:30 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO |
87,719 | $0 | 387,074 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-03 9:19 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO |
543,477 | $0 | 775,984 (Direct) |
View |
| 2022-03-01 Exercise |
2022-03-03 9:19 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO |
36,197 | $0 | 775,984 (Direct) |
View |
| 2021-05-12 Option Award |
2021-05-13 4:04 pm |
N/A 2031-05-12 |
Kadmon Holdings Inc. | KDMN | Konidaris Tasos Director |
116,370 | $0 | 116,370 (Direct) |
View |
| 2021-03-12 Exercise |
2021-03-15 4:06 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO |
87,719 | $0 | 350,877 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 5:03 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO |
434,364 | $0 | 434,364 (Direct) |
View |
| 2020-05-13 Option Award |
2020-05-14 4:28 pm |
2021-05-13 2030-05-13 |
Kadmon Holdings Inc. | KDMN | Konidaris Tasos Director |
102,040 | $0 | 102,040 (Direct) |
View |